articleThe LancetApr 1, 2003Closed access

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Imperial College London · Sahlgrenska University Hospital · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

3,791
total citations
FWCI
350.00
Percentile
100%
References
46
Citations per year

Authors

14

Topics & keywords

Keywords
  • Medicine
  • Atorvastatin
  • Myocardial infarction
  • Hazard ratio
  • Placebo
  • Internal medicine
  • Stroke (engine)
  • Clinical endpoint
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding